Zealand Pharma AS (ZLDPF)
116.06
-4.12
(-3.43%)
USD |
OTCM |
Nov 13, 16:00
Zealand Pharma Max Drawdown (5Y): 74.12% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 74.12% |
| September 30, 2024 | 74.12% |
| August 31, 2024 | 74.12% |
| July 31, 2024 | 74.12% |
| June 30, 2024 | 74.12% |
| May 31, 2024 | 74.12% |
| April 30, 2024 | 74.12% |
| March 31, 2024 | 74.12% |
| February 29, 2024 | 74.12% |
| January 31, 2024 | 74.12% |
| December 31, 2023 | 74.12% |
| November 30, 2023 | 74.12% |
| October 31, 2023 | 74.12% |
| September 30, 2023 | 74.12% |
| August 31, 2023 | 74.12% |
| July 31, 2023 | 74.12% |
| June 30, 2023 | 74.12% |
| May 31, 2023 | 74.12% |
| April 30, 2023 | 74.12% |
| March 31, 2023 | 74.12% |
| February 28, 2023 | 74.12% |
| January 31, 2023 | 74.12% |
| December 31, 2022 | 74.12% |
| November 30, 2022 | 74.12% |
| October 31, 2022 | 74.12% |
| Date | Value |
|---|---|
| September 30, 2022 | 74.12% |
| August 31, 2022 | 74.12% |
| July 31, 2022 | 74.12% |
| June 30, 2022 | 74.12% |
| May 31, 2022 | 74.12% |
| April 30, 2022 | 66.68% |
| March 31, 2022 | 66.68% |
| February 28, 2022 | 66.68% |
| January 31, 2022 | 55.98% |
| December 31, 2021 | 51.41% |
| November 30, 2021 | 51.41% |
| October 31, 2021 | 51.41% |
| September 30, 2021 | 51.41% |
| August 31, 2021 | 51.41% |
| July 31, 2021 | 51.41% |
| June 30, 2021 | 51.41% |
| May 31, 2021 | 51.41% |
| April 30, 2021 | 51.41% |
| March 31, 2021 | 51.41% |
| February 28, 2021 | 51.41% |
| January 31, 2021 | 51.41% |
| December 31, 2020 | 51.41% |
| November 30, 2020 | 51.41% |
| October 31, 2020 | 51.41% |
| September 30, 2020 | 51.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
51.41%
Minimum
Nov 2019
74.12%
Maximum
May 2022
63.60%
Average
70.40%
Median
Max Drawdown (5Y) Benchmarks
| Novo Nordisk AS | 23.65% |
| Genmab AS | 54.19% |
| Ascendis Pharma AS | 61.72% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 18.94 |
| Beta (5Y) | 0.9567 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 57.64% |
| Historical Sharpe Ratio (5Y) | 0.5427 |
| Historical Sortino (5Y) | 1.025 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 19.57% |